Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center.
BACKGROUND
This study aimed to investigate preoperative somatostatin analogs (SSAs) treatment on the surgical outcome in patients with acromegaly.


METHODS
An analysis of 358 patients with acromegaly was conducted. The preoperative medical therapy group (81 patients) received SSA treatment for at least 3 months prior to surgery, while the primary surgery group (277 patients) underwent transsphenoidal surgery directly. Follow-up duration was ≥3 months. Tumor invasion was evaluated by magnetic resonance imaging (MRI) and classified according to the Knosp grading system.


RESULTS
Most patients were diagnosed with macroadenoma. Among all patients (Knosp grades 0-4), preoperative SSA therapy did not significantly improve the curative effect of surgery, according to the levels of growth hormone (GH) and/or insulin-like growth factor 1 (IGF-1) markers. In patients with macroadenoma (Knosp grades 1-3), the remission rates were significantly higher in the SSA group compared to the surgery group when considering GH (56.4% vs. 37.3%, P = 0.048) and IGF-1 (43.2% vs. 17.6%, P = 0.004). In the preoperative medical therapy group, long-term use of SSAs (>6 months) led to higher remission rates (GH, 72.2% vs. 51.0%; and IGF-1, 61.1% vs. 29.8%; P = 0.12 and 0.02, respectively].


CONCLUSIONS
The long-term preoperative SSAs treatment may improve the surgical curative rate in acromegalic patients with invasive macroadenomas (Knosp grades 1-3).
['Duan|Lian|L|', 'Zhu|Huijuan|H|', 'Xing|Bing|B|', 'Gu|Feng|F|']
D000172:Acromegaly D000236:Adenoma D000293:Adolescent D000328:Adult D000368:Aged D005260:Female D006728:Hormones D006801:Humans D008297:Male D008875:Middle Aged D009361:Neoplasm Invasiveness D010911:Pituitary Neoplasms D012074:Remission Induction D012189:Retrospective Studies D013004:Somatostatin D013997:Time Factors D016896:Treatment Outcome
Preoperative treatment Acromegaly Somatostatin analogs Remission rate Invasive macroadenoma